Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001628280-20-009166
Filing Date
2020-06-09
Accepted
2020-06-09 16:57:32
Documents
7
Effectiveness Date
2020-06-09

Document Format Files

Seq Description Document Type Size
1 S-8 auph-2020x05x07formsx8.htm S-8 141010
2 EXHIBIT 4.2 exhibit42bylawno22020.htm EX-4.2 219503
3 EXHIBIT 5.1 exhibit51opinionofblgllp.htm EX-5.1 1369
4 EXHIBIT 23.2 exhibit232consentofpwc.htm EX-23.2 1101
5 EXHIBIT 99.1 exhibit991equityincentivep.htm EX-99.1 114317
6 conformedblgopinions8.jpg GRAPHIC 222866
7 pwc2020auriniausconsents8.jpg GRAPHIC 121134
  Complete submission text file 0001628280-20-009166.txt   951911
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

EIN.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-239048 | Film No.: 20952587
SIC: 2834 Pharmaceutical Preparations